Clinical Trial Update: Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

View source ↗

Summary

Phase 2 trial assessing artefenomel and ferroquine for uncomplicated Plasmodium falciparum malaria with pharmacokinetics and parasiticidal activity data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Infection

Drugs mentioned

• Artefenomel (artefenomel)
• Ferroquine (ferroquine)

Snippet

Sponsor: Sanofi | Conditions: Plasmodium Falciparum Infection | Phase 2 | Status: COMPLETED | Results posted: 2020-12-02